GSE119424 GSE120214 TBXT brachyury inhibition 5 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE119424_GSE120214_TBXT_brachyury inhibition_5_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

small nucleolar RNA host gene 3

Gene

small nucleolar RNA host gene 4

Gene

CROCC pseudogene 2

Gene

small nucleolar RNA host gene 15

Gene

MT-CO2 pseudogene 12

Gene

long intergenic non-protein coding RNA 839

Gene

CDH13 antisense RNA 2

Gene

MT-ATP6 pseudogene 1

Gene

MAGI2 antisense RNA 3

Gene

RAD52 motif containing 1

  • Gene

    small nucleolar RNA host gene 3


  • Gene

    small nucleolar RNA host gene 4


  • Gene

    CROCC pseudogene 2


  • Gene

    small nucleolar RNA host gene 15


  • Gene

    MT-CO2 pseudogene 12


  • Gene

    long intergenic non-protein coding RNA 839


  • Gene

    CDH13 antisense RNA 2


  • Gene

    MT-ATP6 pseudogene 1


  • Gene

    MAGI2 antisense RNA 3


  • Gene

    RAD52 motif containing 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.